Odi Bruckman (@odibro) header
Odi Bruckman (@odibro) profile picture

Odi Bruckman

@odibro

Biotech Stocks News

 Tel Aviv
Joined March 2010
  • Tweets30K
  • Following176
  • Followers12.5K
196Media
Photo by Odi Bruckman (@odibro)Photo by Odi Bruckman (@odibro)Photo by Odi Bruckman (@odibro)Photo by Odi Bruckman (@odibro)Photo by Odi Bruckman (@odibro)Photo by Odi Bruckman (@odibro)Photo by Odi Bruckman (@odibro)Photo by Odi Bruckman (@odibro)Photo by Odi Bruckman (@odibro)Photo by Odi Bruckman (@odibro)
Odi Bruckman retweeted
Bloomberg (@business) profile picture
Bloomberg
@business6 May 2020
Novo Nordisk reports surging sales trib.al/4QgXC2e
Novo Nordisk Joins Other Drugmakers With Gains on Virus Stockpiling

Novo Nordisk Joins Other Drugmakers With Gains on Virus Stockpiling

Novo Nordisk A/S joined other major drugmakers in reporting surging sales as patients snapped up diabetes medicines ahead of coronavirus lockdowns.

bloomberg.com
5
10
21
Odi Bruckman retweeted
M (@bio_clouseau) profile picture
M@bio_clouseau6 May 2020
$NVO Semaglutide in NASH P2 +ve for all 3 doses. Resolution of NASH + no worsening in fibrosis 59% for high dose vs 17% for placebo @ 72 wks. Comparatively $NGM FGF19 @ WK 24 24% vs 9% $ICPT $MDGL $VKTX $AKRO
Image from M (@bio_clouseau)
Image from M (@bio_clouseau)
5
19
2
37
Odi Bruckman retweeted
Moderna (@moderna_tx) profile picture
Moderna
@moderna_tx1 May 2020
Moderna and @LonzaPB announce worldwide strategic collaboration to manufacture Moderna's #vaccine (mRNA-1273) against novel coronavirus. Read more: buff.ly/2Yn8LtG #mRNA
Image from Moderna (@moderna_tx)
9
73
9
178
Odi Bruckman retweeted
Genentech (@genentech) profile picture
Genentech
@genentech28 Apr 2020
#Breaking: Pivotal data evaluating spinal muscular atrophy (SMA) medicine shows study met its primary endpoint in infants with Type 1 #SMA. gene.com/media/press-release…

Genentech: Press Releases | Monday, Apr 27, 2020

Discover the latest news about our company, our products, our policies, and our people.

gene.com
1
2
2
11
#COVID19 $GILD Japan's Prime Minister, Shinzō Abe, says coronavirus drug candidate remdesivir may soon be granted special approval. reuters.com/article/brief-ja…
3
10
3
17
Odi Bruckman retweeted
Bloomberg (@business) profile picture
Bloomberg
@business24 Apr 2020
The WHO and the leaders of France and Germany launch an $8 billion drive to accelerate development of a coronavirus vaccine trib.al/WdMMDQQ
13
79
7
161
FINANCE: Brazil's Real has hit an all-time low against the US Dollar
38
292
60
1,365
A mass testing in the Italian town of Vo’ Euganeo, in the northeast of Italy, found more than 40% of those infected had no symptoms trib.al/p4IL43w
2
9
3
22
Odi Bruckman retweeted
M (@bio_clouseau) profile picture
M@bio_clouseau24 Apr 2020
Key U.S. lawmaker pushes for a ban on mergers until coronavirus pandemic ends reuters.com/article/us-healt…
Key U.S. lawmaker pushes for a ban on mergers until coronavirus pandemic ends

Key U.S. lawmaker pushes for a ban on mergers until coronavirus pandemic ends

The chair of the House Judiciary Committee's antitrust panel on Thursday called for a moratorium on mergers in the next coronavirus stimulus package and a ban on deals that are not directly related...

reuters.com
1
2
1
1
Odi Bruckman retweeted
Reuters (@Reuters) profile picture
Reuters
@Reuters24 Apr 2020
Coronavirus stockpiling drives best Nestle sales growth in years reuters.com/article/us-nestl…
Image from Reuters (@Reuters)
14
64
20
176
Odi Bruckman retweeted
CNBC (@CNBC) profile picture
CNBC
@CNBC24 Apr 2020
Columbia's coronavirus plasma therapy study will be funded by $2.5 million from Amazon. cnb.cx/2Kxv2gg
The FDA just approved Columbia's Covid-19 plasma therapy study, backed by Amazon

The FDA just approved Columbia's Covid-19 plasma therapy study, backed by Amazon

Amazon backed a study at Columbia University to help determine if it's safe and effective to give plasma collected from those who have recovered from the Covid-19 virus to other severely ill patients.

cnbc.com
6
31
2
90
Lysol maker urges people not to inject disinfectants after Trump remarks streetinsider.com/General+Ne…
Disinfectant makers steer consumers away from Trump's coronavirus comments

Disinfectant makers steer consumers away from Trump's coronavirus comments

(This April 24 story fixes word in eighth paragraph) By Martinne Geller and Jonathan Stempel (Reuters) - Makers of household cleaners on Friday took the unusual step of urging people not to...

streetinsider.com
6
11
8
27
Maker of Lysol after Trump comments: 'Under no circumstance' should people inject, ingest disinfectants bit.ly/2KuqGXl
Image from 1010 WINS on 92.3 FM (@1010WINS)
3
16
5
25
Odi Bruckman retweeted
Reuters (@Reuters) profile picture
Reuters
@Reuters24 Apr 2020
Japan's Takeda plans to sell consumer health unit for around $3.7 billion: Nikkei reuters.com/article/us-taked…
Image from Reuters (@Reuters)
1
17
1
33
ORIC Pharmaceuticals prices upsized IPO at $16, the high end of the range $ORIC $IPO #IPO zpr.io/tJ9Pt
ORIC Pharmaceuticals prices upsized IPO at $16, the high end of the range

ORIC Pharmaceuticals prices upsized IPO at $16, the high end of the range

ORIC Pharmaceuticals, a Phase 1 biotech developing small molecule therapies for treatment-resistant cancers, raised $120 million in an upsized IPO by offering 7.5 million shares at $16, the high end...

renaissancecapital.com
1
2
#COVID19 #Remdesivir is having a bad day today... New study found that high dosage of remdesivir may induce testicular toxicity and result in deterioration of sperm parameters in male mice biorxiv.org/content/10.1101/…
Image from Andy Biotech (@AndyBiotech)
Image from Andy Biotech (@AndyBiotech)
35
75
21
137
Odi Bruckman retweeted
dough (@semodough) profile picture
dough
@semodough23 Apr 2020
Next 4/26: PDUFA: $NBIX, Opicapone (Parkinson's disease) 4/27: PDUFA: $UTHR, Trevyent NDA (PAH) 5/14: PDUFA: $BPMC, Avapritinib (GIST) 5/15: PDUFA: $CLVS, Rubraca (prostate cancer
1
6
14
Odi Bruckman retweeted
Brad Loncar (@bradloncar) profile picture
Brad Loncar
@bradloncar23 Apr 2020
The Moderna trial participants are getting their 28 day booster shot. usatoday.com/story/news/2020…
Doctors start giving second round of shots to volunteers in Seattle COVID-19 vaccine trial

Doctors start giving second round of shots to volunteers in Seattle COVID-19 vaccine trial

The volunteers who got shots in the first trial of a possible coronavirus vaccine are getting the second shot — an indicator the trial is going well.

usatoday.com
5
24
1
57
$SNY $PRNB Detailed Phase 2b #MultipleSclerosis data on brain-penetrant BTKi (SAR442168) After 12 wks, 60mg dose achieved 85% / 89% relative reduction in the number of new gadolinium-enhancing T1 / new or enlarging T2 hyperintense lesions, respectively. globenewswire.com/news-relea…
Sanofi brain-penetrant BTK inhibitor significantly reduced disease activity in Phase 2 trial in...

Sanofi brain-penetrant BTK inhibitor significantly reduced disease activity in Phase 2 trial in...

 Sanofi brain-penetrant BTK inhibitor significantly reduced disease activity in Phase 2 trial in relapsing multiple sclerosis Primary and secondary...

globenewswire.com
2
6
7
$RHHBY Roche’s Q1 2020 earnings presentation provides an overview of tiragolumab (anti-TIGIT) trials Deck: roche.com/dam/jcr:f5b0e8e3-6…
Image from SY Investing (@syinvesting)
Image from SY Investing (@syinvesting)
2
7
7
Load more